Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 26501-26550 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06831929
HPV Ends Here: Increasing Uptake of the HPV Vaccine
NARecruiting
2,232 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06201676
Low-Dose Short-Term Ketorolac to Reduce Chronic Opioid Use in Orthopaedic Polytrauma Patients
PHASE4Recruiting
458 participants
Started: Feb 28, 2025 · Completed: Aug 31, 2027
2 conditions2 sponsors2 locations
NCT06812988
Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® Molecule
PHASE2Recruiting
84 participants
Started: Feb 28, 2025 · Completed: Sep 13, 2028
1 condition1 sponsor23 locations
NCT06764316
A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer
PHASE1Recruiting
148 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2033
1 condition1 sponsor10 locations
NCT06778863
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
PHASE1Recruiting
90 participants
Started: Feb 28, 2025 · Completed: Jun 30, 2028
11 conditions1 sponsor15 locations
NCT06768476
CART123 + Ruxolitinib in Relapsed/Refractory AML
PHASE1Recruiting
12 participants
Started: Feb 28, 2025 · Completed: Mar 31, 2045
2 conditions2 sponsors1 location
NCT06673043
Anifrolumab Real-world Treatment Outcomes in Systemic Lupus Erythematosus
N/ARecruiting
100 participants
Started: Feb 28, 2025 · Completed: Jun 30, 2028
1 condition1 sponsor11 locations
NCT06852209
Training Cognition With Neurofeedback After Stroke
NARecruiting
20 participants
Started: Feb 28, 2025 · Completed: Nov 28, 2026
2 conditions1 sponsor1 location
NCT06923371
Moms and Babies Health and Well-being
NARecruiting
1,250 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT06724289
Psilocybin for Prolonged Grief Disorder
EARLY_PHASE1Not yet recruiting
12 participants
Started: Feb 28, 2025 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT06218069
Immuno-pet IMaging ResPonses AdministeRed Immune CheckpoiNt InhibiTor
PHASE2/PHASE3Not yet recruiting
20 participants
Started: Feb 28, 2025 · Completed: Mar 31, 2027
1 condition4 sponsors2 locations
NCT06240897
CURATE.Dtx as a Diagnostic and Management Tool for Delirium
NANot yet recruiting
20 participants
Started: Feb 28, 2025 · Completed: Apr 30, 2026
1 condition3 sponsors1 location
NCT06395688
Drug-Drug Interaction Between THC and AEF0117
PHASE1Not yet recruiting
24 participants
Started: Feb 28, 2025 · Completed: Jun 30, 2025
1 condition2 sponsors0 locations
NCT06858696
A Study to Investigate Pharmacokinetics (PK) and Safety of a Single Dose of Mavorixafor in Participants With Hepatic Impairment (HI) Compared to Matched Healthy Volunteers With Normal Hepatic Function
PHASE1Recruiting
48 participants
Started: Feb 28, 2025 · Completed: Apr 30, 2026
1 condition1 sponsor4 locations
NCT06942416
Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer
PHASE2Recruiting
36 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2028
3 conditions1 sponsor1 location
NCT06610266
Efficacy and Safety of Weifuchun Tablet in Reversing Gastric Intestinal Metaplasia
PHASE4Recruiting
400 participants
Started: Feb 28, 2025 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT06919419
HOTSPOT Study: Implement and Evaluate the PrEP Implementation Strategy
N/ARecruiting
3,600 participants
Started: Feb 28, 2025 · Completed: Mar 1, 2029
3 conditions2 sponsors1 location
NCT05917665
Early Digital, Analyte and Neurologic Biomarkers of Acute and Chronic Brain Injury and Recovery in CQT Instructors
N/AEnrolling by invitation
300 participants
Started: Feb 28, 2025 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05920720
Self-Guided Personalized Treatment for Women
NANot yet recruiting
50 participants
Started: Feb 28, 2025 · Completed: Aug 15, 2025
1 condition2 sponsors1 location
NCT06700694
Technology-Assisted Early Mobilization Program Among Patients in the Intensive Care Units
NANot yet recruiting
138 participants
Started: Feb 28, 2025 · Completed: Apr 30, 2027
1 condition3 sponsors0 locations
NCT06702280
Assessing the Safety of an IGY Supplement on the Gut Microbiome
PHASE1Not yet recruiting
20 participants
Started: Feb 28, 2025 · Completed: Oct 31, 2025
2 conditions2 sponsors1 location
NCT06671548
Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
PHASE3Recruiting
120 participants
Started: Feb 28, 2025 · Completed: Feb 28, 2027
2 conditions1 sponsor1 location
NCT06732583
A Study to Evaluate the Safety and Immunogenicity of Ad5-105K in Adults Aged 18 to 49 Years
PHASE1Not yet recruiting
36 participants
Started: Feb 28, 2025 · Completed: Aug 31, 2025
1 condition2 sponsors0 locations
NCT06831149
Use of SPY Imaging System to Minimize Fistulas After Hypopharyngeal Reconstruction
PHASE2Recruiting
225 participants
Started: Feb 28, 2025 · Completed: Feb 28, 2030
2 conditions1 sponsor1 location
NCT06576115
Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer
PHASE2Recruiting
30 participants
Started: Feb 28, 2025 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT06218732
Revealing Engagement Dynamics Among Semantic Dementia Patients
N/ANot yet recruiting
500 participants
Started: Feb 28, 2025 · Completed: Feb 28, 2027
1 condition1 sponsor1 location
NCT06712043
Testing a Tailored Home Exercise Program to Reduce Pain and Fatigue in Patients with FSHD.
NANot yet recruiting
50 participants
Started: Feb 28, 2025 · Completed: Jul 31, 2025
1 condition2 sponsors0 locations
NCT06829797
A Multicenter Randomized Controlled Phase II Trial of Iparomlimab and Tuvonralimab (QL1706) Combined with SOX Chemotherapy Versus Chemotherapy Alone in the Treatment of Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
PHASE2Not yet recruiting
96 participants
Started: Feb 28, 2025 · Completed: Feb 29, 2028
1 condition1 sponsor0 locations
NCT06829693
Evaluation of the Incidence of Psychiatric Disorders As a Function of First-line Antiepileptic Drug Prescribing Practices: Use of Assurance Maladie Databases
N/ANot yet recruiting
355,000 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2026
2 conditions3 sponsors1 location
NCT06835179
SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer.
PHASE2Not yet recruiting
28 participants
Started: Feb 28, 2025 · Completed: May 31, 2027
3 conditions1 sponsor0 locations
NCT06783062
Activation Failure of Knee Extensors After Anterior Cruciate Ligament Rupture Depending on the Contraction Mode
N/ANot yet recruiting
60 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2027
3 conditions2 sponsors0 locations
NCT06750341
Study of QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated LDL Cholesterol
PHASE2Not yet recruiting
156 participants
Started: Feb 28, 2025 · Completed: Sep 30, 2026
1 condition1 sponsor0 locations
NCT06489262
"Efficacy Trial of Healthy Together (Juntos)"
NARecruiting
750 participants
Started: Feb 28, 2025 · Completed: May 31, 2029
3 conditions2 sponsors1 location
NCT06833216
Familial Breast Cancer in China
N/ANot yet recruiting
500 participants
Started: Feb 28, 2025 · Completed: Feb 28, 2035
2 conditions1 sponsor1 location
NCT06674083
Reliability of the Gyko Inertial Sensor System in Evaluating Jumping and Postural Stability Parameters in Healthy Adults
N/ANot yet recruiting
55 participants
Started: Feb 28, 2025 · Completed: May 31, 2025
2 conditions1 sponsor0 locations
NCT06815042
The Analysis of Efficacy Factors for Autologous Platelet-Rich Plasma Therapy in the Treatment of Elbow Tendinopathy
PHASE4Not yet recruiting
30 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06830668
Same-Day Restart of B/F/TAF in HIV Patients After NNRTI Discontinuation
PHASE4Not yet recruiting
250 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT06791772
Study of CM313(SC) Injection in Systemic Lupus Erythematosus(SLE)
PHASE2Not yet recruiting
150 participants
Started: Feb 28, 2025 · Completed: Feb 28, 2027
1 condition1 sponsor1 location
NCT06833827
'Thrombectomy in High-Risk Pulmonary Embolism - Device Versus Thrombolysis Netherlands': TORPEDO-NL
NARecruiting
111 participants
Started: Feb 28, 2025 · Completed: Jan 31, 2029
1 condition4 sponsors1 location
NCT06784206
Adebrelimab Maintenance Therapy After Concurrent Chemoradiotherapy with Hyperfractionated Radiotherapy in Limited-Stage Small Cell Lung Cancer
PHASE2Not yet recruiting
30 participants
Started: Feb 28, 2025 · Completed: Jan 31, 2028
3 conditions1 sponsor1 location
NCT06744998
Hemopatch Implication After Axillary Dissection for Breast Cancer
NANot yet recruiting
190 participants
Started: Feb 28, 2025 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT06570291
Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis
PHASE3Recruiting
520 participants
Started: Feb 28, 2025 · Completed: Dec 31, 2028
1 condition1 sponsor2 locations
NCT05869825
HFNC vs NIPPV Following Extubation
NARecruiting
200 participants
Started: Feb 27, 2025 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT06834334
Clinical Effectiveness of Advanced Hybrid Closed-loop Systems for Achieving Time in Tight Range Among T1D Patients
N/ARecruiting
189 participants
Started: Feb 27, 2025 · Completed: Dec 31, 2025
1 condition3 sponsors3 locations
NCT06830343
The Safety, Tolerability, and Pharmacokinetics of of SYH9017 in Chinese Participants With Overweight and Obesity
PHASE1Recruiting
66 participants
Started: Feb 27, 2025 · Completed: Oct 1, 2026
1 condition1 sponsor1 location
NCT06678737
CBIT+TMS R33 Phase
PHASE2Recruiting
60 participants
Started: Feb 27, 2025 · Completed: Jul 15, 2030
2 conditions1 sponsor1 location
NCT06800755
Evaluation of the Efficacy and Tolerance of the Medical Device RL3020-DP0364 in Adult Population With Stable Mild Plaque Psoriasis, Dry Skin and Pruritus
NARecruiting
40 participants
Started: Feb 27, 2025 · Completed: Jul 4, 2025
3 conditions1 sponsor1 location
NCT06236607
Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes
NARecruiting
140 participants
Started: Feb 27, 2025 · Completed: Jun 30, 2027
2 conditions2 sponsors2 locations
NCT06561087
Phase II Randomized, Placebo- Controlled Study of Intralesional Nivolumab for High-risk Oral Premalignant Lesions
PHASE2Recruiting
45 participants
Started: Feb 27, 2025 · Completed: May 30, 2029
1 condition1 sponsor1 location
NCT06936852
Ultrasound Guided Serratus Posterior Superior Intercostal Plane Versus PECS II Block In Breast Surgeries
NAActive, not recruiting
50 participants
Started: Feb 27, 2025 · Completed: Aug 20, 2025
1 condition1 sponsor1 location